Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Financial indices provide wider market coverage and reduced single-sector risk versus stock indices. This intro explains practical advantages.
26,745 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Stocks opened sharply lower on May 15, 2026, pushing the S&P 500 onto a heavier red backdrop as tech weakness and inf...
The stock market CAPE ratio has climbed near 40, a level last seen before major crashes in 1929 and 1999, prompting c...
U.S. equities wrapped an eight-week surge led by tech giants, erasing early-2026 losses. Investors weigh AI-driven ea...
Latin America's fintech leaders have faced a choppy earnings season, but patient investors see potential. This guide ...
A director at The Cheesecake Factory recently disclosed a sizable stock move. This guide breaks down what that inside...
Looking ahead five years, XRP faces a mix of regulatory, market, and adoption factors. This article breaks down scena...
CoreWeave’s latest trading session highlighted the tension between high-growth AI clouds and the realities of funding...
Domino's stock trades at a modest multiple, with a business built on digital ordering and value pricing. This guide e...
A bold alliance between Allseas and a mining innovator aims to commercialize deep-sea nodule recovery. This strategic...
Natera shows growth through AI-enabled cell-free DNA tests and a widening data moat, positioning it as a leading nate...
As quantum progress accelerates, investors look for tech stocks before Q-Day that blend growth with resilience. Here ...